Top Markets
#1 Pleasing Gold Pleasing Gold +1,496.37%
#2 PulseChain PulseChain +58.12%
#3 Ontology Gas Ontology Gas +37.96%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.44%
#5 BOOK OF MEME BOOK OF MEME +30.66%
#6 Unit Pump Unit Pump +25.83%
#7 Pump.fun Pump.fun +25.83%
#8 Neiro Neiro +25.36%
#9 ConstitutionDAO ConstitutionDAO +23.34%
#10 Collect on Fanable Collect on Fanable +23.27%
Coin of the day
Pleasing Gold Pleasing Gold
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
Classificação em ações #26169
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Preço da ação
$1.73
Valor de mercado
$42.88M
Variação (1 dia)
2.16%
Variação (1 ano)
-18.85%
País
PL
Negociar Molecure S.A. (MOC)

Categoria

Healthcare
Lucros da Molecure S.A. (MOC)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Molecure S.A., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Molecure S.A. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US